Sort
50,496 grants matching “lung cancer”
Co-targeting IGF-1R and Glutaminase in Ewing Sarcoma
$391,186Hamid Band · University Of Nebraska Medical Center · R21 · FY2025 · CA
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$391,184Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA
Signaling by Neuregulins and ErbB4 in Breast Cancer
$391,179David F Stern · Yale University · R01 · FY2009 · CA
Signaling by Neuregulins and ErbB4 in Breast Cancer
$391,179David F Stern · Yale University · R01 · FY2010 · CA
Role of KAT5 in lung cancer
$391,170Susumu Kobayashi · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Role of KAT5 in lung cancer
$391,170Susumu Kobayashi · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
High Throughput Screen to Identify Inhibitors of the Golgi GOLPH3 Pathway
$391,163Seth J Field · University Of California, San Diego · R01 · FY2018 · CA
Role of GAS41 in Human Cancer
$391,163Xiaobing Shi · Van Andel Research Institute · R01 · FY2018 · CA
Determining the mechanisms by which bone morphogenetic protein inhibition promotes survival/neurogenesis and to trigger AMPK hyperactivation that includes neuronal and cancer death cell
$391,156John Langenfeld · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
Characterization of the interaction between inflammation and cancer progression
$391,135Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Assessment of Effectiveness of IMPT vs. IMRT through Phase II Randomized Clinical Trials
$391,126Bruce D. Minsky · Massachusetts General Hospital · U19 · FY2014 · CA
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
$391,109Antonio Fojo · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Blocking tumor progression in therapy-responsive RET aberration-associated cancer
$391,096Jie Wu · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · CA
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
$391,020Evripidis Gavathiotis · Albert Einstein College Of Medicine · R01 · FY2023 · CA
The B7x pathways in the tumor microenvironment
$391,020Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2022 · CA
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
$391,020Evripidis Gavathiotis · Albert Einstein College Of Medicine · R01 · FY2022 · CA
The B7x pathways in the tumor microenvironment
$391,020Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2023 · CA
Translational Research in Cancer
$391,000Karen E Knudsen · Thomas Jefferson University · P30 · FY2020 · CA
Cancer Center Support Grant
$391,000Steven Terry Rosen · Beckman Research Institute/City Of Hope · P30 · FY2020 · CA
Virginia Mason Community Clinical Oncology Program
$391,000Jacqueline Vuky · Benaroya Research Inst At Virginia Mason · U10 · FY2007 · CA
BIOMOLECULAR ANALYSIS USING LIQUID CRYSTALS
$390,982Nicholas L Abbott · University Of Wisconsin-Madison · R01 · FY2012 · CA
Development and evaluation of apoptosis targeted therapies in lung cancer
$390,981King Kwong · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Novel mechanisms of B cell tumorigenesis and relapse
$390,932Ping Xie · Rutgers, The State Univ Of N.J. · R01 · FY2025 · CA
Novel mechanisms of B cell tumorigenesis and relapse
$390,930Ping Xie · Rutgers, The State Univ Of N.J. · R01 · FY2024 · CA
Role of the SWI/SNF complex in tumor suppression
$390,919Charles W Roberts · St. Jude Children'S Research Hospital · R01 · FY2022 · CA